Cyclin/CDK inhibitors of the 9p21 chromosomal region and hematological malignancies;Inhibiteurs des cyclines/CDK de la region chromosomique 9p21 et hemopathies malignes

Bulletin du Cancer

Volumn 85, Issue 9, 1998, Pages 747-754

  Quesnel, Bruno ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

9p21; Acute lymphoblastic leukemia; Acute myeloblastic leukemia; Myelodysplastic syndrome; p15(INK4b); p16(INK4a)

Indexed keywords

CYCLIN DEPENDENT KINASE; PROTEIN P16; PROTEIN P53;

ACUTE LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; CELL CYCLE; CHROMOSOME 9P; ENZYME INHIBITION; GENE LOCUS; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; MYELODYSPLASTIC SYNDROME; POINT MUTATION; REVIEW; TUMOR SUPPRESSOR GENE; VIRUS CELL TRANSFORMATION;

CELL CYCLE PROTEINS; CHROMOSOMES, HUMAN, PAIR 9; CYCLIN-DEPENDENT KINASE INHIBITOR P15; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLIN-DEPENDENT KINASES; HEMATOLOGIC NEOPLASMS; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE; LEUKEMIA, MYELOCYTIC, ACUTE; MYELODYSPLASTIC SYNDROMES; NEOPLASM PROTEINS; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS;

EID: 0031787289     PISSN: 00074551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (43)

1. INK4/MTS1 gene transcript expressed in B-cell malignancies. Oncogene 1995 ; 11 : 21-9.
2. Stone S, Jiang P, Dayananth P, Tavtigian SV, Katcher H, Parry D et al. Complex structure and regulation of the P16 (MTS1) locus. Cancer Res 1995 ; 55 : 2988-94.
3. Quelle DE, Zindy F, Ashmun RA, Sherr CJ. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell 1995 ; 83 : 993-1000.
4. Bartek J, Bartkova J, Lukas J. The retinoblastoma protein pathway and the restriction point. Curr Opin Cell Biol 1996 ; 8 : 805-14.
5. Sherr CJ. Cancer cell cycles. Science 1996 ; 274 : 1672-7.
6. INK4a : a gene with a dual capacity to encode unrelated proteins that inhibit cell cycle progression. Oncogene 1996 ; 12 : 2041-4.
7. Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV et al. A cell cycle regulator potentially involved in genesis of many tumor types. Science 1994 ; 264 : 436-40.
8. Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K, Carson DA. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 1994 ; 368 : 753-6.
9. INK4A) gene in primary B-cell lymphomas. Blood 1995 ; 86 : 2724-31.
10. INK4 genes in hematologic malignancies. Leak Lymphoma 1996 ; 23 : 235-45.
11. INK4a gene and hematological malignancies. Leuk Lymphoma 1996 ; 22 : 11-24.
12. INK4B) display frequent homozygous deletions in primary cells from T-but not from B-cell lineage acute lymphoblastic leukemias. Blood 1994 ; 84 : 4038-44.
13. INK4b/MTS2 in pediatric acute lymphoblastic leukemia. Blood 1995 ; 85 : 2321-30.
14. Guidal Giroux C, Gerard B, Cave H, Duval M, Rohrlich P, Elion J et al. Deletion mapping indicates that MTS1 is the target of frequent deletions at chromosome 9p21 in paediatric acute lymphoblastic leukaemias. Br J Haematol 1996 ; 92 : 410-9.
15. INK4b gene deletions in primary leukemias. Blood 1995 ; 86 : 311-5.
16. INK4 gene inactivation in acute lymphocytic leukemia. Blood 1995 ; 85 : 3431-6.
17. INK4b/MTS2 in pediatric acute lymphoblastic leukemia. Blood 1995 ; 85 : 2321-30.
18. ARF encoding exons in T-cell acute lymphoblastic leukemia. Blood 1998 ; 91 : 1016-20.
19. Quesnel B, Preudhomme C, Philippe N, Vanrumbeke M, Dervite I, Lai JL et al. p16 gene homozygous deletions in acute lymphoblastic leukemia. Blood 1995 ; 85 : 657-63.
20. Cayuela JM, Gardie B, Sigaux F. Disruption of the multiple tumor suppressor gene MTS1/p16(INK4a)/CDKN2 by illegitimate V(D)J recombinase activity in T-cell acute lymphoblastic leukemias. Blood 1997; 90 : 3720-6.
21. INK4B homozygous gene deletions in infant acute lymphoblastic leukemia. Leukemia 1997 ; 11 : 979-83.
22. INK4b. Cancer Res 1996 ; 56 : 722-7.
23. INK4A characterize the major types of hematological malignancies. Cancer Res 1997 ; 57 : 837-41.
24. Herman JG, Graff JR, Myöhänen S, Nelkin BD, Baylin SB. Methylation-specific PCR : a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 1996 ; 93 : 9821-6.
25. Scott RE. Differentiation, differentiation/gene therapy and cancer. Pharmacology et Therapeutics 1997 ; 73 : 51-65.
26. Li ML, Cardoso AA, Sansilvestri P, Hatzfeld A, Brown EL, Sookdeo H et al. Additive effects of steel factor and antisense TGF-beta 1 oligodeoxynucleotide on CD34+ hcmatopoietic progenitor cells. Leukemia 1994 ; 8 : 441-5.
27. Stranks G, Height SE, Mitchell P, Jadayel D, Yuille MA, De Lord C et al. Deletions and rearrangement of CDKN2 in lymphoid malignancy. Blood 1995 ; 85 : 893-901.
28. Takeuchi S, Bartram CR, Seriu T, Miller CW, Tobler A, Janssen JW et al. Analysis of a family of cyclin-dependent kinase inhibitors : p15/MTS2/INK4B, p16/MTS1/INK4A, and p18 genes in acute lymphoblastic leukemia of childhood. Blood 1995 ; 86 : 755-60.
29. Ogawa S, Hirano N, Sato N, Takahashi T, Hangaishi A, Tanaka K et al. Homozygous loss of the cyclin-dependent kinase 4-inhibitor (p16) gene in human leukemias. Blood 1994 ; 84 : 2431-5.
30. Kim DH, Moldwin RL, Vignon C, Bohlander SK, Suto Y, Giordano L et al. TEL-AML1 translocations with TEL and CDKN2 inactivation in acute lymphoblastic leukemia cell lines. Blood 1996 ; 88 : 785-94.
31. Quesnel B, Guillerm G, Vereecque R, Wattel E, Preudhomme C, Bauters F et al. Methylation of the p15 gene in myelodysplastic syndromes is frequent and acquired during disease progression. Blood 1998; 91 : 2985-90.
32. Sill H, Goldman JM, Cross NC. Homozygous deletions of the p16 tumor-suppressor gene are associated with lymphoid transformation of chronic myeloid leukemia. Blood 1995 ; 85 : 2013-6.
33. Martinez Delgado B, Fernandez Piqueras J, Garcia MJ, Arranz E, Gallego J, Rivas C et al. Hypermethylation of a 5′ CpG island of p16 is a frequent event in non-Hodgkin's lymphoma. Leukemia 1997 ; 11 : 425-8.
34. Watl genes are associated with aggressive variants of mantle cell lymphomas. Blood 1997 ; 89 : 272-80.
35. Koduru PR, Zariwala M, Soni M, Gong JZ, Xiong Y, Broome JD. Deletion of cyclin-dependent kinase 4 inhibitor genes P15 and P16 in non-Hodgkin's lymphoma. Blood 1995 ; 86 : 2900-5.
36. Gernone A, Iolascon A, Pietrafesa A, Dammacco F. p16 gene analysis in multiple myeloma (Mm). Leukemia 1996 ; 10 : 1401.
37. INK4C genes in multiple myeloma. Br J Haematol 1997 ; 96 : 98-102.
38. Ng MH, Chung YF, Lo KW, Wickham NW, Lee JC, Huang DP. Frequent hypermethylation of p16 and p15 genes in multiple myeloma. Blood 1997 ; 89 : 2500-6.
39. INK4B/MTS2 in human leukemias and lymphomas. Cancer Res 1995 ; 55 : 1436-40.
40. Newcomb EW, Thomas A, Selkirk A, Lee SY, Potmesil M. Frequent homozygous deletions of D13S218 on 13q14 in B-cell chronic lymphocytic leukemia independent of disease stage and retinoblastoma gene inactivation. Cancer Res 1995 ; 55 : 2044-7.
41. INK4 (9p21), and DBM (13q14)) in B-cell chronic lymphocytic leukemia. Mol Carcinog 1995 ; 14 : 141-6.
42. Hatta Y, Yamada Y, Tomonaga M, Koeffler HP. Extensive analysis of the retinoblastoma gene in adult T cell leukemia/lymphoma (ATL). Leukemia 1997 ; 11 : 984-9.
43. Yamada Y, Hatta Y, Murata K, Sugawara K, Ikeda S, Mine M et al. Deletions of p15 and/or p16 genes as a poor-prognosis factor in adult T-cell leukemia. J Clin Oncol 1997 ; 15 : 1778-85.